Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?

Harms and risks to groups and third-parties can be significant in the context of research, particularly in data-centric studies involving genomic, artificial intelligence, and/or machine learning technologies. This article explores whether and how United States federal regulations should be adapted...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Bioethics Vol. 25; no. 2; pp. 47 - 61
Autores principales: Chapman, Carolyn Riley, Quinn, Gwendolyn P., Natri, Heini M., Berrios, Courtney, Dwyer, Patrick, Owens, Kellie, Heraty, Síofra, Caplan, Arthur L.
Formato: Journal Article
Publicado: Taylor & Francis Ltd Feb2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182607506&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 182607506
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15265161
        FKZ
      jtl: American Journal of Bioethics
      issn: 15265161
      maglogo: N
    pubinfo:
      dt: Feb2025
      vid: 25
      iid: 2
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        182607506
        10.1080/15265161.2023.2276161
        182607506
      ppf: 47
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Consideration and Disclosure of Group Risks in Genomics and Other Data-Centric Research: Does the Common Rule Need Revision?
      aug:
        au:
          Chapman, Carolyn Riley
          Quinn, Gwendolyn P.
          Natri, Heini M.
          Berrios, Courtney
          Dwyer, Patrick
          Owens, Kellie
          Heraty, Síofra
          Caplan, Arthur L.
        affil: NYU Grossman School of Medicine
      sug:
        subj:
          Genetic Research Ethical Issues
          Genomics
          Government Regulations United States
          Data Analytics
          United States
          Research Subject Recruitment Ethical Issues
          Consent Ethical Issues
          Communities
      ab: Harms and risks to groups and third-parties can be significant in the context of research, particularly in data-centric studies involving genomic, artificial intelligence, and/or machine learning technologies. This article explores whether and how United States federal regulations should be adapted to better align with current ethical thinking and protect group interests. Three aspects of the Common Rule deserve attention and reconsideration with respect to group interests: institutional review board (IRB) assessment of the risks/benefits of research; disclosure requirements in the informed consent process; and criteria for waivers of informed consent. In accordance with respect for persons and communities, investigators and IRBs should systematically consider potential group harm when designing and reviewing protocols, respectively. Research participants should be informed about any potential group harm in the consent process. We call for additional public discussion, empirical research, and normative analysis on these issues to determine the right regulatory and policy path forward.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N